PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced today that Tom Moore, Chairman & CEO of Advaxis, will present a corporate overview of the Company at the 6th Annual International BIO-Europe Spring 2012 partnering conference at the Amsterdam RAI Convention Center in Amsterdam on Tuesday, March 20, 2012 at 11:00am CET in Room E104, Level 1. BIO-Europe Spring provides life science companies with high caliber partnering opportunities.
